Why the study?
Does magnesium administration prevent postoperative atrial fibrillation in patients undergoing cardiac surgery?
Does magnesium administration prevent postoperative atrial fibrillation in patients undergoing cardiac surgery?
Magnesium administration is an effective prophylactic measure for preventing postoperative atrial fibrillation after cardiac surgery, though it does not significantly alter length of stay or mortality.
Answers are grounded in this paper and cite their sources.
Supports magnesium prophylaxis to reduce postoperative AF after cardiac surgery; confirms efficacy in meta-analysis of randomized trials.
OBJECTIVES: To assess the efficacy of the administration of magnesium as a method for the prevention of postoperative atrial fibrillation (AF) and to evaluate its influence on hospital length of stay (LOS) and mortality. METHODS: Literature search and meta-analysis of the randomised control studies published since 1966. RESULTS: 20 randomised trials were identified, enrolling a total of 2490 patients. Study sample size varied between 20 and 400 patients. Magnesium administration decreased the proportion of patients developing postoperative AF from 28% in the control group to 18% in the treatment group (odds ratio 0.54, 95% confidence interval (CI) 0.38 to 0.75). Data on LOS were available from seven trials (1227 patients). Magnesium did not significantly affect LOS (weighted mean difference -0.07 days of stay, 95% CI -0.66 to 0.53). The overall mortality was low (0.7%) and was not affected by magnesium administration (odds ratio 1.22, 95% CI 0.39 to 3.77). CONCLUSION: Magnesium administration is an effective prophylactic measure for the prevention of postoperative AF. It does not significantly alter LOS or in-hospital mortality.
No takes yet. Share an insight, caveat, or question.
Steven P. Miller (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: